Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Strong support for Nifty at 9968: 4 stocks to buy, sell today: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, the larger trend for Nifty is still intact, however some slide is not rule out and there exists a strong support at 9968.

    • Buy Havells India, sell Dr Reddy's Laboratories: Sandeep Wagle

      is of the view that one can buy Havells India and sell Dr Reddy's Laboratories.

    • Buy IRB Infrastructure, Engineers India, Repco Home Finance, PVR: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying IRB Infrastructure Developers, Engineers India, Repco Home Finance and PVR.

    • Dr Reddy's Labs can slide to Rs 2425, says Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Dr Reddy's Labs can slide to Rs 2425.

    • Dr Reddy’s tanks 6% on dismal Q1; brokerages turn cautious on stock

      Say headwinds in US hit financials, highlight further risks in terms of remediation delays at its plants.

    • Buy, Sell, Hold: Here are 9 stocks analysts are tracking today

      ITC, ICICI Bank, Dr Reddy’s Labs and ONGC, among others, are on the radar of investors on Friday.

    • Buy Britannia Industries; sell UltraTech Cement, Jubilant Foodworks: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Britannia Industries and sell UltraTech Cement and Jubilant Foodworks.

    • Buy Punjab National Bank, Dr Reddy's Labs: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com advises buying Punjab National Bank and Dr Reddy's Labs.

    • Wondering which stock will outperform in Q1? Morgan Stanley lists out 4 stocks which could double PAT

      Morgan Stanley said Tata Motors and Tata Steel should be the biggest positive contributors to Sensex earnings.

    • Buy BEML, Dr Reddy's Labs, Kajaria Ceramics, Power Grid; sell PVR: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy BEML, Dr Reddy's Laboratories, Kajaria Ceramics and Power Grid Corporation of India and can sell PVR.

    • Buy Dr Reddy’s Labs; sell Pidilite Industries: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one may buy Dr Reddy’s Labs and sell Pidilite Industries.

    • Bull's Eye: Buy BPCL, Dr Reddy's, Federal Bank, Mindtree, Pidilite, Titan, PFC

      Ashish Kyal of Waves Strategy Advisors suggests buying BPCL with a target of Rs 690 and Mindtree with a target of Rs 570.

    • Retail investors should be cautious while investing in market: Rahul Arora

      In an interview to CNBC-TV18, Rahul Arora, CEO at Nirmal Bang Institutional Equities shared his readings and outlook on the market and specific stocks and sectors.

    • Buy, Sell, Hold: 9 stocks and 7 sectors are on the radar of analysts’ today

      ITC, Wipro, TCS and Titan, among others are being tracked by analysts on Tuesday.

    • Buy Dr Reddy's Labs, Britannia Industries: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests buying Dr Reddy's Labs and Britannia Industries.

    • Prefer Dr Reddy's, Sun Pharmaceutical: Hemant Thukral

      Hemant Thukral of Aditya Birla Money is of the view that one may prefer Dr Roddy’s Laboratories and Sun Pharmaceutical.

    • Short PNB; buy Aurobindo Pharma, Dr Reddy's Labs, Prabhat Dairy: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can short Punjab National Bank and can buy Aurobindo Pharma, Dr Reddy's Laboratories and Prabhat Dairy.

    • Top 10 fundamentally strong stocks to buy on dips which could give up to 22% return

      Most experts have a target of 32,000 – 33,000 on the S&P BSE Sensex which translates into an upside of about 5 percent. Investors will be better off staying with stocks which can outperform markets by a wide margin.

    • Indian pharma companies should increase base of sales in next few years: Nirmal Bang

      Formulations plant of Dr Reddy's Laboratories at Srikakulam gets inspected and gets 1 observation from United States Foods and Drug Authority (US-FDA). The plant was inspected with zero observations last time.

    • Here are SP Tulsian's top trading ideas

      In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian ofsptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

    • Remain invested in Dr Reddy's Laboratories: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, one may remain invested in Dr Reddy's Laboratories.

    • Buy, Sell, Hold: 3 stocks and 1 sector on analysts' radar today

      CLSA has maintained its buy call on Dr Reddy's, with a target price of Rs 3,280. It feels biosimilars will drive scale-up in emerging markets.

    • Buy Dr Reddy's Laboratories, sell Exide Industries: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com suggests buying Dr Reddy's Laboratories and selling Exide Industries.

    • Dr Reddy’s US FDA developments get a thumbs up from brokerages

      Cite positive news on the regulatory front, but pain for Duvvada plant may remain, they say.

    • Buy Aurobindo Pharma, Dr Reddy's Laboratories; sell HPCL: Rajat Bose

      Rajat Bose of rajatkbose.com advises selling Hindustan Petroleum Corporation and suggests buying Aurobindo Pharma, Dr Reddy's Laboratories.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347